Navigation Links
Pioneer(R) Brand Soybeans From DuPont Deliver Step-Change in Soybean Yields
Date:7/10/2008

New Generation of Soybean Varieties is Largest Product Launch in Pioneer

History

DES MOINES, Iowa, July 10 /PRNewswire/ -- DuPont business Pioneer Hi-Bred today announced the launch of a new generation of soybean varieties that will deliver unprecedented productivity gains to North American soybean growers. The introduction of the new Y Series soybeans represents the largest volume of commercial products launched in the 82-year history of Pioneer.

Pioneer intends to bring to market for 2009 planting enough seed to plant about 9 million acres of the Y series soybeans in 32 new varieties. The entire line has demonstrated a 5 percent yield advantage against key competitor varieties in more than 1,800 on-farm comparisons, with some varieties yielding 6 to 10 percent better than their competitors.

"The Y Series from Pioneer represents a step-change in soybean productivity," said Paul Schickler, Pioneer president and DuPont vice president and general manager. "With the Y Series yield advantage, this new line has the potential to add about 19 million bushels of soybeans into U.S. production. In a time of tight supplies and soaring demand, that is a strong boost for producers and the industry."

The launch of the new Y Series is the result of a proprietary matrix of traits and technologies Pioneer researchers have been developing and deploying to accelerate product development. Pioneer is employing its exclusive Accelerated Yield Technology (AYT) and marker-assisted selection to boost the yield potential and improve the agronomic performance of these varieties.

Pioneer is the industry leader in developing marker-assisted selection processes to introduce key defensive traits to protect soybean yield from harmful pests such as soybean cyst nematode, Phytophthora root rot and brown stem rot. Recently, Pioneer announced that it has also identified new markers for Asian soybean rust, soybean aphids and frogeye leaf spot.

"The Y Series generation of Pioneer soybean varieties represents the combination of all of our industry-leading soybean research capabilities into a single game-changing package," Schickler said. "It is a great example of how Pioneer will increase soybean yields by 40 percent in the next 10 years."

Pioneer intends to offer Y Series soybeans for the 2009 planting season in maturities ranging from Group 0 to Group VII. These new varieties will be easily identified with a "Y" in the Pioneer variety number, such as 93Y70.

Pioneer Hi-Bred, a DuPont business, is the world's leading source of customized solutions for farmers, livestock producers and grain and oilseed processors. With headquarters in Des Moines, Iowa, Pioneer provides access to advanced plant genetics in nearly 70 countries.

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

Forward-Looking Statements: This news release contains forward-looking statements based on management's current expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects," "anticipates," "plans," "intends," "projects," "indicates," and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in DuPont's filings with the Securities and Exchange Commission, particularly its latest annual report on Form 10-K, as well as others, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions of countries in which the company does business; competitive pressures; successful integration of structural changes, including acquisitions, divestitures and alliances; research and development of new products, including regulatory approval and market acceptance, and seasonality of sales of agricultural products.

The DuPont Oval Logo, DuPont(TM), The miracles of science(TM), and Pioneer(R) are registered trademarks or trademarks of DuPont or its affiliates.

Contact: Doyle Karr

515-270-3428

Doyle.a.karr-1@usa.dupont.com


'/>"/>
SOURCE DuPont
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
2. Pioneer(R) Surgical Technology Announces First Human Implants of its NuNec(TM) Cervical Arthroplasty Device
3. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
4. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
5. Indevus Announces Allergan as New Partner for SANCTURA Brand
6. AMDLs Chinese Subsidiary Wins Key Brand Excellence Award for Anti-Aging Treatment
7. Nastech Announces Promotion of Gordon Brandt, M.D. to President
8. Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit
9. Manhattan Research Ranks the Top Pharmaceutical Branded Websites by Rx Request Rates
10. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
11. Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBIs Early Commercialization Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
(Date:6/23/2016)... ... , ... Supplyframe, the Industry Network for electronics hardware design ... Located in Pasadena, Calif., the Design Lab’s mission is to bring together inventors ... and brought to market. , The Design Lab is Supplyframe’s physical representation of ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a ... discoveries to the medical community, has closed its Series ... Matthew Nunez . "We have received a ... the capital we need to meet our current goals," ... provide us the runway to complete validation on the ...
Breaking Biology Technology:
(Date:4/19/2016)... DUBAI , UAE, April 20, 2016 ... can be implemented as a compact web-based "all-in-one" system ... in the biometric fingerprint reader or the door interface ... requirements of modern access control systems. The minimal dimensions ... the ID readers into the building installations offer considerable ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
(Date:3/31/2016)... PROVIDENCE, R.I. , March 31, 2016  Genomics ... leadership of founding CEO, Barrett Bready , M.D., ... addition, members of the original technical leadership team, including ... Vice President of Product Development, Steve Nurnberg and Vice ... have returned to the company. Dr. Bready ...
Breaking Biology News(10 mins):